Franklin Resources’s Olema Pharmaceuticals OLMA Stock Holding History

Franklin Resources’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.2M	Sell	1,218,957 -1,257,708	-51%	-$28M	﹤0.01%	1025
2025 Q4	$61.9M	Sell	2,476,665 -535,304	-18%	-$9.53M	0.02%	576
2025 Q3	$29.5M	Hold	3,011,969	–	–	0.01%	830
2025 Q2	$12.8M	Hold	3,011,969	–	–	﹤0.01%	1052
2025 Q1	$11.3M	Buy	3,011,969 +2,738,263	+1,000%	+$13.8M	﹤0.01%	1065
2024 Q4	$1.6M	Buy	273,706 +258,625	+1,715%	+$2.58M	﹤0.01%	1806
2024 Q3	$177K	Hold	15,081	–	–	﹤0.01%	2664
2024 Q2	$163K	Buy	15,081 +2,210	+17%	+$24K	﹤0.01%	2598
2024 Q1	$146K	Hold	12,871	–	–	﹤0.01%	2656
2023 Q4	$181K	Hold	12,871	–	–	﹤0.01%	2371
2023 Q3	$159K	Buy	+12,871	New	+$131K	﹤0.01%	2380
2021 Q3	–	Sell	-412,205	Closed	-$11.5M	–	2486
2021 Q2	$11.5M	Buy	412,205 +42,200	+11%	+$1.2M	﹤0.01%	989
2021 Q1	$12.3M	Hold	370,005	–	–	0.01%	931
2020 Q4	$17.8M	Buy	+370,005	New	+$17.3M	0.01%	837

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Franklin Resources's OLMA Position: Q1 2026 in Review

Franklin Resources reduced its Olema Pharmaceuticals (OLMA) stake by 51% in Q1 2026, selling an estimated $28M and leaving 1,218,957 shares worth $18.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Franklin Resources first reported a position in OLMA in Q4 2020 and has held it in 14 quarters since. The position peaked at $61.9M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Franklin Resources held 1,218,957 shares of Olema Pharmaceuticals worth $18.2M as of Q1 2026.
Franklin Resources sold 1,257,708 Olema Pharmaceuticals shares in Q1 2026, an estimated $28M.
Olema Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1025 holding.
Franklin Resources first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 14 quarters since.
Franklin Resources's Olema Pharmaceuticals position peaked at $61.9M in Q4 2025.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.